Research reports from industry and university researchers continue to indicate that constipation affects a broad swathe of the population. The numbers suggest that some 10% of the population has experienced constipation within the last six months and some smaller fraction experience it on a chronic basis. Therefore the demand for constipation treatments remain large but also the industry has responded with a plethora of remedy products.
New entrants into the market may feel some intimidation by the large number of companies already supplying constipation treatments. The underlying situation suggests there’s no need to worry. The reason is that constipation remains an “idiopathic” disease, meaning that there is no clear indicator of its cause. As a result, most people don’t know a priori the most effective treatment and must try a few before hitting upon one that works.
Currently, the treatment market can be divided into 4 types. There are supplemental agents, which don’t require FDA approval. There are herbal agents, which usually fall outside FDA jurisdiction but has occasionally experienced periods of regulation. There are general laxative agents that are either over-the-counter or by prescription. There are the new “targeted therapies” that attempt to address molecular and hormonal causes of constipation.


























